Balancing act

摘要

Adrian swinburne and his colleagues at Generics Group could be described as the alchemists of the technology community. It would be unfair to describe the innovations they take under their wing as base metal, but gold ― in the form of a sound, long-term commercial future ― is certainly the objective. This is traditionally a skill at which the UK's record is patchy at best. 'Excellent technologists don't necessarily identify the best routes for exploitation of their technologies,' said Swinburne. 'There's a balance between developing high-calibre technologies and the business case that will support them. The lack of that balance often contributes to failure.'